Cite
HARVARD Citation
Nicoll, A. et al. (2019). Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels. Alimentary pharmacology & therapeutics. 49 (10), pp. 1314-1322. [Online].